ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada
· Delayed Price · Currency is CAD 0.500
-0.020 (-3.85%)
At close: Apr 28, 2026
ZYUS Life Sciences Market Cap
ZYUS Life Sciences has a market cap or net worth of CAD 40.26 million as of April 29, 2026. Its market cap has decreased by -26.83% in one year.
Market Cap
40.26M
Enterprise Value
55.05M
Revenue
465.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since July 4, 2023, ZYUS Life Sciences's market cap has decreased from 80.32M to 40.26M, a decrease of -49.88%. That is a compound annual growth rate of -21.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 41.87M | -25.30% |
| Dec 31, 2025 | 56.05M | -19.81% |
| Dec 31, 2024 | 69.90M | 11.19% |
| Dec 29, 2023 | 62.86M | -21.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LSL Pharma Group | 49.70M |
| Rubicon Organics | 35.14M |
| iAnthus Capital Holdings | 34.86M |
| Optimi Health | 33.87M |
| C21 Investments | 51.85M |
| MediPharm Labs | 31.86M |
| BioNxt Solutions | 58.32M |
| Mountain Valley MD Holdings | 29.71M |